Divis Laboratories Ltd Performance
Open
3934
Traded Value (Cr)
237.32 Cr
Prev. Close
3927.35
VWAP
3802.87
Volume
3,08,127
Face Value
2
Divis Laboratories Ltd Fundamentals
Divis Laboratories Ltd F&O
Divis Laboratories Ltd Financials
Resistance and Support
₹3,918.07
PIVOT
 Resistance | |
|---|---|
| First Resistance | ₹3,962.883 |
| Second Resistance | ₹4,014.367 |
| Third Resistance | ₹4,059.183 |
 Support | |
|---|---|
| First Resistance | ₹3,866.583 |
| Second Resistance | ₹3,821.767 |
| Third Resistance | ₹3,770.283 |
| RSI | 63.407 |
| MACD | 132.963 |
| ADX | 53.391 |
| CCI | 52.790 |
Delivery and Volume
About Divis Laboratories Ltd
Divis Laboratories Ltd holds a prominent position in the Indian pharmaceutical industry, focusing on researching, developing, and producing a diverse array of Active Pharmaceutical Ingredients (APIs) and Intermediates. The company's state-of-the-art manufacturing facilities comply with global regulatory standards, including the United States Food and Drug Administration (US FDA) and the European Medicines Agency (EMA) approvals. Divis Laboratories' product portfolio covers a diverse range of therapeutic areas, catering to various healthcare needs. Their products find applications in areas such as cardiovascular, anti-infective, central nervous system, anti-inflammatory, and many others. The company places a strong emphasis on research and development, continuously striving to innovate and develop new molecules and processes. This commitment to R&D has enabled them to stay at the forefront of the pharmaceutical industry and provide cutting-edge solutions to global healthcare challenges. Divis Laboratories Ltd was established in 1990 in Hyderabad, India. Since its inception, the company has grown to become a prominent player in the pharmaceutical industry. With a focus on research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and Intermediates, Divis Laboratories has earned a reputation for delivering high-quality products and services both in the domestic and international markets. The company's commitment to innovation, compliance with global regulatory standards, and diverse product portfolio have contributed to its consistent growth and success over the years. Divis Laboratories continues to expand its presence in the pharmaceutical market, solidifying its position as a leading Indian pharmaceutical company. Divis Laboratories Ltd was actively traded on the stock market. It is listed on various stock exchanges in India, such as the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). Being a prominent player in the pharmaceutical industry, Divis Laboratories has garnered significant investor interest and has become a well-established company in the Indian stock market. Divis Laboratories Ltd had gone public through an initial public offering (IPO) in March 2003. The specific issue date for the IPO was March 19, 2003. During the IPO, Divis Laboratories offered its shares to the public for the first time, allowing investors to purchase the company's stock. The IPO was a significant milestone in the company's journey as it transitioned from a privately held entity to a publicly traded company on the stock exchanges. In recent times the share price of Divi's Laboratories Ltd has been experiencing positive momentum, reflecting the company's strong performance and investor confidence in its pharmaceutical products and services. Divis Laboratories operates with a commitment to quality and compliance. Its manufacturing facilities adhere to stringent international standards, including certifications from regulatory bodies such as the United States Food and Drug Administration (US FDA), the European Medicines Agency (EMA), and other international agencies. These certifications testify to the company's adherence to global best practices, ensuring the safety, efficacy, and consistency of its products. The company's diversified product portfolio covers a wide range of therapeutic areas, including cardiovascular, central nervous system, anti-infective, oncology, and more. Its products find application in various medical treatments, catering to diverse healthcare needs across the globe. Divis Laboratories Ltd is the flagship company of the Divis Group, which is a conglomerate of companies with diverse business interests. Divis Laboratories Ltd: Divis Laboratories Ltd serves as the primary pharmaceutical firm involved in the exploration, advancement, and production of Active Pharmaceutical Ingredients (APIs) and Intermediates. Divi's Nutraceuticals: A division of Divis Laboratories focused on the development and manufacturing of nutraceutical products, including vitamins, minerals, and dietary supplements. Divi's Laboratories USA Inc: This subsidiary is based in the United States and handles sales, marketing, and customer support for the company's products in North America. Divis Labs SRL: A subsidiary in Europe, Divis Labs SRL manages the company's European operations and serves as a hub for sales and distribution across the region. Divis Laboratories Japan K.K.: Another subsidiary, this entity handles sales and distribution in Japan, strengthening the company's presence in the Asian market. Divis Laboratories (Shanghai) Co. Ltd. : This subsidiary is located in China and plays a vital role in the company's operations and expansion in the Chinese market. The stock prices of individual companies are influenced by various factors, resulting in continuous fluctuations and creating a dynamic trading environment throughout the day. Factors such as company performance, market sentiment, economic conditions, industry trends, and global events can impact the share price of a company on the stock market. You can find the Divis Laboratories Ltd share price, from the above section.Company Establishment
Divis Laboratories Ltd Total Stocks & IPO Raise Out
About The Company
Divis Laboratories Ltd group of companies
Divis Laboratories Ltd Share Price Today
Managing Director
Murali K Divi
Founded
1990
NSE Symbol
DIVISLAB
Divis Laboratories Ltd Management
| Name | Designation |
|---|---|
| Murali K Divi | Chairman & Managing Director |
| N V Ramana | Executive Director |
| Madhusudana Rao Divi | Whole Time Director (Projects) |
| Kiran S Divi | Whole Time Director & CEO |
| G Suresh Kumar | Independent Director |
| Ranga Rao Ravipati | Independent Director |
| K V K Seshavataram | Independent Director |
| Ramesh B V Nimmagadda | Chairman(Non Exe)&Director(Ind |
| Nilima Motaparti | Whole Time Director -Commercia |
| S Ganapaty | Independent Director |
| Sunaina Singh | Independent Director |
| Kosaraju Veerayya Chowdary | Independent Director |
| Satish Choudhury | Company Sec. & Compli. Officer |